Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
In addition to downregulation of GCLC, we found increased expression of glutaredoxin GLRX5 and a very small, but significant, increase in GGT1 expression in tumors compared to nontumor tissues (Fig 2B and D)
The scale during this phase can be misleading due to water retention fluctuations, especially around dose increases
doi: 10.3945/jn.108.095638
Laboratory Handling and Storage Store at 28 C , protected from light and humidity
US$ 28.51
US$ 22.49
US$ 27.54
US$ 26.18
US$ 24.51
US$ 25.21
